Concepedia

Publication | Open Access

A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells

DOIFull Paper Access

78

Citations

43

References

2011

Year

Megumi Kawamoto, Tomohisa Horibe, Masayuki Kohno, Koji Kawakami
BMC Cancer

Abstract

TfR-lytic peptide might provide a potent and selective anticancer therapy for patients.

References

YearCitations

Page 1